Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
6 hedge funds and large institutions have $4.17M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
500% more funds holding
Funds holding: 1 → 6 (+5)
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
463% more capital invested
Capital invested by funds: $742K → $4.17M (+$3.43M)
12.73% more ownership
Funds ownership: 2.54% → 15.27% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$1.65M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$502K |
| 3 |
Jane Street
New York
|
+$467K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$355K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$345K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$742K |
PILL Hedge Fund Activity: Q4 2021 in Review
6 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q4 2021, worth a combined $4.17M — up 463% from $742K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PILL positions and 1 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $1.65M. The largest seller was Flow Traders U.S., exiting entirely with an estimated $742K sold.
- 6 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q4 2021, up from 1 in Q3 2021.
- Funds reported $4.17M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q4 2021, up 463% quarter-over-quarter.
- 6 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q4 2021 and 1 closed out, a net change of +5 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q4 2021 was Goldman Sachs, an estimated $1.65M added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q4 2021 was Flow Traders U.S., an estimated $742K sold.
Based on aggregated 13F filings for Q4 2021.